Home
Research
About
Services
Contact
Partners
Sign up
Blog
More
Diurnal Group
26 March 2021
Efmody (Chronocort) EU approval
Back on Track
3 March 2021
Recap on the pipeline potential
Important period ahead
23 February 2021
H1 2020 Results
Final stretch
18 January 2021
Chronocort
Evolving CAH Treatments
11 November 2020
Introducing DITEST
Shifting Gear
30 September 2020
Alkindi US Approval
Another important milestone
16 September 2020
Initiation of Coverage
Wake up, time to fly
Please subscribe to receive our research, articles and invitations as soon as they are available. Our research is classified as a ‘minor non-monetary benefit’ as defined by
the Markets in Financial Instruments Directive II
.
Subscribe
Thank you for subscribing